Scopus BioPharma Inc. (SCPS)
OTCMKTS
· Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Jan 21, 2025, 3:00 PM EST
Scopus BioPharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 |
| Cash & Equivalents | 0.36 | 0.12 | 7.94 | 1.83 | 0.04 | 0 | Upgrade
|
| Cash & Short-Term Investments | 0.36 | 0.12 | 7.94 | 1.83 | 0.04 | 0 | Upgrade
|
| Cash Growth | -68.69% | -98.43% | 333.54% | 4885.71% | 2113.67% | -98.95% | Upgrade
|
| Other Receivables | - | - | - | - | - | 0.03 | Upgrade
|
| Receivables | - | - | - | - | - | 0.03 | Upgrade
|
| Prepaid Expenses | 0.13 | 0.27 | 0.24 | 0.14 | 0.08 | 0.1 | Upgrade
|
| Other Current Assets | - | - | - | - | 0.65 | - | Upgrade
|
| Total Current Assets | 0.5 | 0.39 | 8.18 | 1.97 | 0.77 | 0.13 | Upgrade
|
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | - | Upgrade
|
| Total Assets | 0.5 | 0.39 | 8.19 | 1.97 | 0.77 | 0.13 | Upgrade
|
| Accounts Payable | 0.17 | 0.18 | 0.12 | 0.09 | 0.16 | - | Upgrade
|
| Accrued Expenses | 10.74 | 7.03 | 4.05 | 1.43 | 0.69 | 0.11 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 2.28 | - | - | Upgrade
|
| Other Current Liabilities | 0.09 | 0.25 | - | - | - | 0.02 | Upgrade
|
| Total Current Liabilities | 11 | 7.45 | 4.17 | 3.81 | 0.85 | 0.14 | Upgrade
|
| Total Liabilities | 11 | 7.45 | 4.17 | 3.81 | 0.85 | 0.14 | Upgrade
|
| Common Stock | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 48.62 | 46.52 | 45.54 | 14.22 | 3.58 | 0.94 | Upgrade
|
| Retained Earnings | -58.13 | -53.06 | -41.46 | -14.5 | -3.64 | -0.95 | Upgrade
|
| Comprehensive Income & Other | 0.02 | -0.04 | -0.09 | -1.57 | -0.03 | -0.01 | Upgrade
|
| Total Common Equity | -9.45 | -6.56 | 4.02 | -1.83 | -0.08 | -0.01 | Upgrade
|
| Minority Interest | -1.05 | -0.5 | - | - | - | - | Upgrade
|
| Shareholders' Equity | -10.5 | -7.06 | 4.02 | -1.83 | -0.08 | -0.01 | Upgrade
|
| Total Liabilities & Equity | 0.5 | 0.39 | 8.19 | 1.97 | 0.77 | 0.13 | Upgrade
|
| Total Debt | - | - | - | 2.28 | - | - | Upgrade
|
| Net Cash (Debt) | 0.36 | 0.12 | 7.94 | -0.45 | 0.04 | 0 | Upgrade
|
| Net Cash Growth | -68.69% | -98.43% | - | - | 2113.67% | -98.95% | Upgrade
|
| Net Cash Per Share | 0.01 | 0.01 | 0.46 | -0.03 | 0.00 | 0.00 | Upgrade
|
| Filing Date Shares Outstanding | 42.08 | 39.58 | 21.09 | 15.73 | 12.51 | 10.77 | Upgrade
|
| Total Common Shares Outstanding | 39.78 | 21.09 | 21.09 | 14.58 | 12.51 | 10.77 | Upgrade
|
| Working Capital | -10.51 | -7.06 | 4.01 | -1.83 | -0.09 | -0.01 | Upgrade
|
| Book Value Per Share | -0.24 | -0.31 | 0.19 | -0.13 | -0.01 | -0.00 | Upgrade
|
| Tangible Book Value | -9.45 | -6.56 | 4.02 | -1.83 | -0.08 | -0.01 | Upgrade
|
| Tangible Book Value Per Share | -0.24 | -0.31 | 0.19 | -0.13 | -0.01 | -0.00 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.